指南&解读

订阅

MedSci主页 / 所有栏目 / 指南&解读

2015版《中国抗癌协会乳腺癌诊治指南与规范》：药物治疗策略的解读

2016-07-06 SIBCS整理 中华乳腺病杂志

中国抗癌协会乳腺癌诊治指南
关注

王碧芸，龚成成，胡夕春 复旦大学附属肿瘤医院肿瘤内科 为推动中国乳腺癌的规范化诊治，中国抗癌协会乳腺癌专业委员会于2007年发布了第1版《中国抗癌协会乳腺癌诊治指南与规范》（简称《指南》），并结合乳腺癌领域最新循证医学进展每2年进行1次更新，指导中国乳腺癌的诊断与治疗。最新公布的2015版《指南》从乳腺癌筛查、影像诊断、病理诊断、手术及全身治疗等方面对乳腺癌临床诊治策略进行了规范。本文

王碧芸，龚成成，胡夕春
复旦大学附属肿瘤医院肿瘤内科

为推动中国乳腺癌的规范化诊治，中国抗癌协会乳腺癌专业委员会于2007年发布了第1版《中国抗癌协会乳腺癌诊治指南与规范》（简称《指南》），并结合乳腺癌领域最新循证医学进展每2年进行1次更新，指导中国乳腺癌的诊断与治疗。最新公布的2015版《指南》从乳腺癌筛查、影像诊断、病理诊断、手术及全身治疗等方面对乳腺癌临床诊治策略进行了规范。本文从乳腺癌的内分泌治疗、抗HER2分子靶向治疗、化疗与骨保护治疗的角度出发，对2015版《指南》药物治疗策略的更新内容进行了解读。



原文参见：中华乳腺病杂志. 2016;10(2):65-70.

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=119551, encodeId=bc9611955145, content=好文章，百姓也能从中学到好多医学知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Sat Sep 10 17:05:00 CST 2016, time=2016-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=95560, encodeId=f0be95560d5, content=学习学习！, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Tue Aug 02 21:54:00 CST 2016, time=2016-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1972836, encodeId=ddef19e283692, content=<a href='/topic/show?id=639121868f8' target=_blank style='color:#2F92EE;'>#中国抗癌协会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21868, encryptionId=639121868f8, topicName=中国抗癌协会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a3a2500014, createdName=fmq_28614553, createdTime=Fri Nov 04 17:19:00 CST 2016, time=2016-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1604719, encodeId=7fd41604e1908, content=<a href='/topic/show?id=9c279166488' target=_blank style='color:#2F92EE;'>#诊治指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91664, encryptionId=9c279166488, topicName=诊治指南)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d4719270101, createdName=ms9651749636653578, createdTime=Fri Jul 08 02:19:00 CST 2016, time=2016-07-08, status=1, ipAttribution=)]
    2016-09-10 1e10c84am36(暂无匿称)

    好文章，百姓也能从中学到好多医学知识

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=119551, encodeId=bc9611955145, content=好文章，百姓也能从中学到好多医学知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Sat Sep 10 17:05:00 CST 2016, time=2016-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=95560, encodeId=f0be95560d5, content=学习学习！, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Tue Aug 02 21:54:00 CST 2016, time=2016-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1972836, encodeId=ddef19e283692, content=<a href='/topic/show?id=639121868f8' target=_blank style='color:#2F92EE;'>#中国抗癌协会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21868, encryptionId=639121868f8, topicName=中国抗癌协会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a3a2500014, createdName=fmq_28614553, createdTime=Fri Nov 04 17:19:00 CST 2016, time=2016-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1604719, encodeId=7fd41604e1908, content=<a href='/topic/show?id=9c279166488' target=_blank style='color:#2F92EE;'>#诊治指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91664, encryptionId=9c279166488, topicName=诊治指南)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d4719270101, createdName=ms9651749636653578, createdTime=Fri Jul 08 02:19:00 CST 2016, time=2016-07-08, status=1, ipAttribution=)]
    2016-08-02 1dd8c52fm63(暂无匿称)

    学习学习！

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=119551, encodeId=bc9611955145, content=好文章，百姓也能从中学到好多医学知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Sat Sep 10 17:05:00 CST 2016, time=2016-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=95560, encodeId=f0be95560d5, content=学习学习！, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Tue Aug 02 21:54:00 CST 2016, time=2016-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1972836, encodeId=ddef19e283692, content=<a href='/topic/show?id=639121868f8' target=_blank style='color:#2F92EE;'>#中国抗癌协会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21868, encryptionId=639121868f8, topicName=中国抗癌协会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a3a2500014, createdName=fmq_28614553, createdTime=Fri Nov 04 17:19:00 CST 2016, time=2016-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1604719, encodeId=7fd41604e1908, content=<a href='/topic/show?id=9c279166488' target=_blank style='color:#2F92EE;'>#诊治指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91664, encryptionId=9c279166488, topicName=诊治指南)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d4719270101, createdName=ms9651749636653578, createdTime=Fri Jul 08 02:19:00 CST 2016, time=2016-07-08, status=1, ipAttribution=)]
    2016-11-04 fmq_28614553

    #中国抗癌协会#

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=119551, encodeId=bc9611955145, content=好文章，百姓也能从中学到好多医学知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Sat Sep 10 17:05:00 CST 2016, time=2016-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=95560, encodeId=f0be95560d5, content=学习学习！, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Tue Aug 02 21:54:00 CST 2016, time=2016-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1972836, encodeId=ddef19e283692, content=<a href='/topic/show?id=639121868f8' target=_blank style='color:#2F92EE;'>#中国抗癌协会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21868, encryptionId=639121868f8, topicName=中国抗癌协会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a3a2500014, createdName=fmq_28614553, createdTime=Fri Nov 04 17:19:00 CST 2016, time=2016-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1604719, encodeId=7fd41604e1908, content=<a href='/topic/show?id=9c279166488' target=_blank style='color:#2F92EE;'>#诊治指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91664, encryptionId=9c279166488, topicName=诊治指南)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d4719270101, createdName=ms9651749636653578, createdTime=Fri Jul 08 02:19:00 CST 2016, time=2016-07-08, status=1, ipAttribution=)]
    2016-07-08 ms9651749636653578

    #诊治指南#

    0